Shelly M. Xie
Hebei Medical University(CN)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Cancer-related molecular mechanisms research, PI3K/AKT/mTOR signaling in cancer, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → ETV4 overexpression promotes progression of non–small cell lung cancer by upregulating PXN and MMP1 transcriptionally(2019)76 cited
- → Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors(2014)61 cited
- → Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment(2023)24 cited
- → HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer(2023)24 cited
- → High mobility group box-1 protects against Aflatoxin G1-induced pulmonary epithelial cell damage in the lung inflammatory environment(2020)15 cited
- → Personal Evolution in Thighplasty Techniques for Patients Following Massive Weight Loss(2017)15 cited
- → Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synthesis in non‐small cell lung cancer(2022)11 cited
- → Macroscopic and microscopic imaging modalities for diagnosis and monitoring of urogenital schistosomiasis(2021)1 cited
- → Topoisomerase I Inhibition in ETV4‐overexpressed Non‐Small Cell Lung Cancer Promotes Replication and Transcription Mediated R‐Loop Accumulation and DNA Damage(2025)1 cited